Home LiteratureArticle Details
PMID: 18590740 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.

Journal of molecular biology ·Vol. 381 ·No. 4 ·2008-09-12 ·Pages 928-40

Babon JJ, Sabo JK, Soetopo A, Yao S, Bailey MF, Zhang JG, Nicola NA, Norton RS

Abstract

Suppressor of cytokine signalling 3 (SOCS3) is responsible for regulating the cellular response to a variety of cytokines, including interleukin 6 and leukaemia inhibitory factor. Identification of the SOCS box domain led to the hypothesis that SOCS3 can associate with functional E3 ubiquitin ligases and thereby induce the degradation of bound signalling proteins. This model relies upon an interaction between the SOCS box, elonginBC and a cullin protein that forms the E3 ligase scaffold. We have investigated this interaction in vitro using purified components and show that SOCS3 binds to elonginBC and cullin5 with high affinity. The SOCS3-elonginBC interaction was further characterised by determining the solution structure of the SOCS box-elonginBC ternary complex and by deletion and alanine scanning mutagenesis of the SOCS box. These studies revealed that conformational flexibility is a key feature of the SOCS-elonginBC interaction. In particular, the SOCS box is disordered in isolation and only becomes structured upon elonginBC association. The interaction depends upon the first 12 residues of the SOCS box domain and particularly on a deeply buried, conserved leucine. The SOCS box, when bound to elonginBC, binds tightly to cullin5 with 100 nM affinity. Domains upstream of the SOCS box are not required for elonginBC or cullin5 association, indicating that the SOCS box acts as an independent binding domain capable of recruiting elonginBC and cullin5 to promote E3 ligase formation.

MeSH Terms
Alanine/metabolism Amino Acid Sequence Animals Binding Sites Calorimetry Cullin Proteins/chemistry,metabolism Elongin Epitopes Magnetic Resonance Spectroscopy Mice Models, Molecular Molecular Sequence Data Mutagenesis Mutant Proteins/metabolism Protein Binding Suppressor of Cytokine Signaling 3 Protein Suppressor of Cytokine Signaling Proteins/chemistry,metabolism Transcription Factors/chemistry,isolation & purification,metabolism Ubiquitin-Protein Ligases/chemistry,metabolism Ultracentrifugation src Homology Domains
Chemicals
Cullin Proteins Elongin Epitopes Mutant Proteins Socs3 protein, mouse Suppressor of Cytokine Signaling 3 Protein Suppressor of Cytokine Signaling Proteins Transcription Factors cullin5 protein, mouse Ubiquitin-Protein Ligases Alanine
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Babon Jeffrey J
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia. babon@wehi.edu.au
Sabo Jennifer K
Soetopo Alfreda
Yao Shenggen
Bailey Michael F
Zhang Jian-Guo
Nicola Nicos A
Norton Raymond S
References (50)
50 references, click to expand
  1. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines.
    Genes Dev. 2004 Dec 1;18(23):2867-72 PMID: 15574593
  2. The SOCS box: a tale of destruction and degradation.
    Trends Biochem Sci. 2002 May;27(5):235-41 PMID: 12076535
  3. A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin.
    Biochim Biophys Acta. 2004 Nov 29;1695(1-3):133-70 PMID: 15571813
  4. Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation.
    Structure. 2007 Nov;15(11):1493-504 PMID: 17997974
  5. Protein backbone angle restraints from searching a database for chemical shift and sequence homology.
    J Biomol NMR. 1999 Mar;13(3):289-302 PMID: 10212987
  6. Clinical studies with granulocyte colony stimulating factor (G-CSF) in patients receiving cytotoxic chemotherapy.
    Behring Inst Mitt. 1988 Aug;(83):234-9 PMID: 2467651
  7. MOLMOL: a program for display and analysis of macromolecular structures.
    J Mol Graph. 1996 Feb;14(1):51-5, 29-32 PMID: 8744573
  8. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function.
    J Biol Chem. 2005 May 13;280(19):18573-8 PMID: 15781449
  9. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity.
    Nat Med. 2004 Jul;10(7):739-43 PMID: 15208705
  10. Structural disorder throws new light on moonlighting.
    Trends Biochem Sci. 2005 Sep;30(9):484-9 PMID: 16054818
  11. Extended disordered proteins: targeting function with less scaffold.
    Trends Biochem Sci. 2003 Feb;28(2):81-5 PMID: 12575995
  12. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis.
    Immunity. 2004 Feb;20(2):153-65 PMID: 14975238
  13. Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9033-8 PMID: 10430890
  14. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.
    Blood. 2007 Sep 1;110(5):1466-74 PMID: 17510322
  15. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3.
    Structure. 2006 Aug;14(8):1285-92 PMID: 16905102
  16. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability.
    Mol Cell. 2006 Apr 21;22(2):205-16 PMID: 16630890
  17. Intrinsically unstructured proteins and their functions.
    Nat Rev Mol Cell Biol. 2005 Mar;6(3):197-208 PMID: 15738986
  18. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling.
    J Biol Chem. 2004 Feb 20;279(8):6905-10 PMID: 14699146
  19. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    J Leukoc Biol. 2004 Jul;76(1):237-44 PMID: 15107455
  20. Biophysical characterization of elongin C from Saccharomyces cerevisiae.
    Biochemistry. 2000 Sep 12;39(36):11137-46 PMID: 10998253
  21. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.
    Proc Natl Acad Sci U S A. 2006 May 16;103(20):7637-42 PMID: 16675548
  22. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3.
    Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9324-9 PMID: 11481489
  23. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
    Virology. 2006 Jan 20;344(2):263-6 PMID: 16303161
  24. A family of cytokine-inducible inhibitors of signalling.
    Nature. 1997 Jun 26;387(6636):917-21 PMID: 9202125
  25. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.
    Genes Cells. 1999 Jun;4(6):339-51 PMID: 10421843
  26. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
    J Biol Chem. 2003 Jan 3;278(1):661-71 PMID: 12403768
  27. The C-terminus of CIS defines its interaction pattern.
    Biochem J. 2007 Jan 1;401(1):257-67 PMID: 16961462
  28. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2.
    J Biol Chem. 2001 Apr 20;276(16):12530-8 PMID: 11278610
  29. Discovering high-affinity ligands for proteins: SAR by NMR.
    Science. 1996 Nov 29;274(5292):1531-4 PMID: 8929414
  30. Negative regulators of cytokine signal transduction.
    Cell Mol Life Sci. 1999 Sep;55(12):1568-77 PMID: 10526574
  31. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases.
    J Biol Chem. 2008 Mar 21;283(12):8005-13 PMID: 18187417
  32. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients.
    Blood. 1988 Dec;72(6):2074-81 PMID: 3264199
  33. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex.
    Nature. 2002 Apr 18;416(6882):703-9 PMID: 11961546
  34. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
    EMBO J. 1999 Jan 15;18(2):375-85 PMID: 9889194
  35. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.
    J Biol Chem. 2002 Nov 1;277(44):42394-8 PMID: 12228220
  36. Tyrosine-phosphorylated SOCS3 interacts with the Nck and Crk-L adapter proteins and regulates Nck activation.
    J Biol Chem. 2004 Sep 3;279(36):37662-9 PMID: 15173187
  37. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR.
    J Biomol NMR. 1996 Dec;8(4):477-86 PMID: 9008363
  38. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.
    Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2071-6 PMID: 10051596
  39. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop.
    EMBO J. 1999 Mar 1;18(5):1309-20 PMID: 10064597
  40. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain.
    FEBS J. 2005 Dec;272(23):6120-30 PMID: 16302975
  41. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
    Science. 2003 Nov 7;302(5647):1056-60 PMID: 14564014
  42. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
    J Biol Chem. 2000 Sep 22;275(38):29338-47 PMID: 10882725
  43. The molecular genetics of prostate cancer.
    Urology. 2003 Nov;62(5 Suppl 1):3-10 PMID: 14607212
  44. Jaks and STATs: biological implications.
    Annu Rev Immunol. 1998;16:293-322 PMID: 9597132
  45. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
    Genes Dev. 2004 Dec 15;18(24):3055-65 PMID: 15601820
  46. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis.
    Nat Med. 2005 Aug;11(8):892-8 PMID: 16007096
  47. Sedimentation equilibrium analysis of protein interactions with global implicit mass conservation constraints and systematic noise decomposition.
    Anal Biochem. 2004 Mar 15;326(2):234-56 PMID: 15003564
  48. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.
    Science. 1999 Apr 16;284(5413):455-61 PMID: 10205047
  49. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo.
    Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13261-5 PMID: 11606785
  50. Culture medium for enterobacteria.
    J Bacteriol. 1974 Sep;119(3):736-47 PMID: 4604283
Article Info
Journal
Journal of molecular biology
Abbr.
J Mol Biol
ISSN
1089-8638
Published
2008-09-12
Epub
2008-00-20
Pages
928-40
Language
English
Region
England
NLM ID
2985088R
PMCID
PMC3652878
Subset
IM
Grants
NCI NIH HHS · R01 CA022556 · United States
NCI NIH HHS · R37 CA022556 · United States
NCI NIH HHS · R37 CA022556-31 · United States
NCI NIH HHS · CA22556 · United States
Databases
PDB
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com